TATU

DRUG 1

300

UNEMPLOYMENT, HOUSING INSTABILITY, SOCIAL PROBLEMS-STIGMA, ISOLATION & LONELINESS, VICTIMIZATION, INCARCERATION

WHAT IS….SMI-PROBLEMS?

400

EVERY 2-4 WEEKS, HALDOL, PROLIXIN, RISPERDAL CONSTA

WHAT IS….LONG ACTING INJECTIONS(DECANOATE OR DEPOT)

500

CHRONIC, OR RECURRENT ILLNESS, DISABILITY & MULTIPLE PHYSICAL, EMOTIONAL, SOCIAL& ECONOMIC PROBLEMS

What is WHAT IS….SMI-CAREGIVER BURDEN ASSOCIATED WITH

DRUG 2

300

NONADHERANCE,SUBSTANCE ABUSE, SITUATION STRESSORS

WHAT IS….SMI-PREDICATIVE FACTORS OF REVOLVING DOOR ADMISSIONS?

400

ANOSOGNOSIA, CLIENTS/FAMILY CAREGIVER BELIEFS, ADVERSE SE, TREATMENT INADEQUATE/EFFICACY, SUBSTANCE ABUSE, TREATMENT PROVIDERS, DRUG COSTS

WHAT IS….MED ADHERENCE-FACTORS RELATED TO NONADHERANCE

500

SEROQUEL XR, INVEGA

WHAT IS….EXTENDED RELEASE TABLETS SEROQUEL XR, INVEGA

DRUG 3

300

HOLISTIC CARE THAT ADDRESSES PHYSICAL & MENTAL HEALTH, CRISIS INTERVENTION, PROMOTE ADHERENCE, EMPOWER PTS TO SET TREATMENT GOALS, CLEINTS AND FAMILY PSYCH EDUCATION, SUBSTANCE ABUSE TREATMENT, CASE MANAGEMENT

WHAT IS….NI FOR SMI?

400

SCHIZO,BIPOLAR,SEVER DEPRESSION, PTSD

WHAT IS….DISORDERS OF SERIOUS MENTAL ILLNESS(SMI)

500

HIGHLY SEDATING, SEVERE OH(GIVE AT NIGHT, SUPINE AFTER 30 MINUTES AFTER IM INJECTION), VISION CHANGES—BLINDNESS FROM LONG TERM THERAPY, PHOTOSENSITIVITY

WHAT IS….DRUG PROFILE: CHLORPROMAZINE(THORAZINE)

DRUG 4

300

ASSERTIVE COMMUNITY TREATMENT(COMPREHENSIVE SERVICES), FAMILY SUPPORT & PARTNERSHIPS(NAMI FAMILY TO FAMILY), SOCIAL SKILLS TRAINING(ADLS TO INTERPERSONAL SKILLS, ANGER MANAGEMENT), VOCATIONAL REHAB (VOCATIONAL TRAINING, SUPPORTED EMPLOYMENT, JOB PLACEMENT, WITH TRAINING), COMMUNITY RESOURCES (WAY STATIONS , HUMANIM), ADVANCE DIRECTIVES(MANAGEMENT OF RELAPSES) CONSUMER OR PEER PROGRAMS(ON OUR OWN, WELLNESS & RECOVERY ACTION PLANS(WRAP))

WHAT IS….EBT APPROACHES FOR SMI?

400

COMPLETE HEALTH HISTORY-CARDIAC STATUS, DIAETES,HISTORY OF SEIZURES, PREGNANCY, VARIATION RELATED TO AGE, BASELINE VS., WEIGHT& LAB STUDIES, DO MENTAL STATUS EXAM

WHAT IS….NI-PRIOR TO ADMINISTRATION

500

HIGH POTENCY=LOW SEDATION, LOW ACH. HIGH EPS, SEIZURES, PO, IM, IV DEPOT PREPARATIONS

WHAT IS….DRUG PROFILE: HALOPERIDOL(HALDOL)

DRUG 5

300

TREATMENT ISSUES-NONADHERENCE, MED SE, RESIDUAL SYMPTOMS, RELAPSE, TREATMENT INADEQUACY, COMORBID CONDITIONS

WHAT IS….SMI PROBLEMS? TREATMENT ISSUES-NONADHERENCE, MED SE, RESIDUAL SYMPTOMS, RELAPSE, TREATMENT INADEQUACY, COMORBID CONDITIONS

400

REDUCTION OF PSYCHOTIC SYMPTOMS, PATIENT FAM EDUCATION-VERBALIZE PURPOSE, SCHEDULE & ADMINISTRATION, ADVERSE EFFECTS, REPORT ADVERSE EFFECTS, ADHERE TO MEDS

WHAT IS…? NI-GOALS AND OUTCOME

500

RISPERDAL M-TAB, ZYPREXA ZYDIS, ABILIFY DISC-MELT

WHAT IS….PREPARATIONS: ORAL DISINTEGRATING, TABLETS(ODT)